ArticleFrontiers in public health2025
Association between endocrine disrupting chemicals and female infertility: a study based on NHANES database.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Potential of Volatilomics as Female Fertilization Biomarkers in Assisted Reproductive Techniques.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Controversy persists regarding the impact of endocrine disrupting chemicals (EDCs) on female infertility, and the specific EDCs that cause female infertility remain unclear. This study aims to examine the associations between various EDCs metabolites and female infertility using data from the female population in the National Health and Nutrition Examination Survey (NHANES) conducted between 2001 and 2006. Methods: A cross-sectional study on reproductive-age women aged 18-45 years was conducted, with data retrieved from the NHANES database. Multivariate logistic regression analysis was performed to evaluate the association between EDCs metabolites and female infertility. Subgroup analysis was applied to stratify by age and body mass index (BMI). Results were summarized using an odds ratio (OR) with a 95% confidence interval (CI). Results: A total of 3,982 women were enrolled, comprising 463 infertile women and 3,519 control women. The results showed that increased exposure to EDCs metabolites (including DnBP, DEHP, DiNP, DEHTP, PAEs, Equol, PFOA, and PFUA) was significantly associated with female infertility, with odds ratios of 2.10 (95% CI: 1.59, 2.48), 1.36 (95% CI: 1.05, 1.79), 1.62 (CI: 1.31, 1.97), 1.43 (95% CI: 1.22, 1.78), 1.43 (95% CI: 1.26, 1.75), 1.41 (95% CI: 1.17, 2.35), 1.34 (95% CI: 1.15, 2.67), and 1.58 (95% CI: 1.08, 2.03), respectively. Sensitivity analyses confirmed the robustness of these findings. The subgroup analysis also indicated that increased age and BMI may exacerbate the risk of female infertility among those exposed to EDCs metabolites. Conclusions: This study indicates that exposure to EDCs metabolites such as PAEs, equol, and PFASs are associated with female infertility. These findings provide valuable evidence for preventing female infertility from the perspective of EDCs exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.